DUNTAFY
LIVE

Serial Number

88377490

Owner

MorphoSys AG

Attorney

Frances M. Jagla

Filing Date

Apr 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

DUNTAFY Trademark

Serial Number: 88377490 • Registration: 6161314

DUNTAFY is a trademark filed by MorphoSys AG on April 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MorphoSys AG (48 trademarks)

Lena-Christ-Strasse 48
82152 Martinsried/Planegg , DE

Entity Type: 03

Incyte Holdings Corporation (151 trademarks)

Wilmington, DE 19803

Entity Type: 03

Trademark Details

Filing Date

April 9, 2019

Registration Date

September 29, 2020

Published for Opposition

July 14, 2020

Goods & Services

pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis

research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 29, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2024 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 1, 2024 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 24, 2024 ASCK
REGISTERED-PRINCIPAL REGISTER
Sep 29, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 8, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 8, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 8, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 8, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 28, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 4, 2019 GNFN
FINAL REFUSAL E-MAILED
Dec 4, 2019 GNFR
FINAL REFUSAL WRITTEN
Dec 4, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 19, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 19, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 19, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 19, 2019 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 7, 2019 AMPX
ASSIGNED TO LIE
May 6, 2019 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 28, 2019 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2019 NWOS
NEW APPLICATION ENTERED
Apr 12, 2019 NWAP